References
- Borges CM, Ramalho R, Bajanca M, et al. Implementação de um sistema de custeio por actividades nos hospitais do SNS. Revista Portuguesa de Saúde Pública. 2010;9:141–160.
- Fukuda H, Lee J, Imanaka Y. Variations in analytical methodology for estimating costs of hospital-acquired infections: a systematic review. J Hospital Infect. 2011;77:93–105. doi: 10.1016/j.jhin.2010.10.006
- Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis. 2001;33:S94–S106. doi: 10.1086/321863
- DGS. Programa Nacional para a Saúde de Pessoas Idosas. Direção Geral de Saúde; 2004.
- Schairer WW, Sing DC, Vail TP, et al. Causes and frequency of unplanned hospital readmission after total hip arthroplasty. Clin Orthopaed Related Res. 2014;472:464–470. doi: 10.1007/s11999-013-3121-5
- Fonseca F. Infecção em artroplastias do joelho. Revista Portuguesa de Ortopedia e Traumatologia. 2006: 109–125.
- Bertucci FN, Tedrus GMAS. Infecções em próteses ortopédicas: revisão da literatura. Anais do XV Encontro de Iniciação Científica da PUC-Campinas Campinas; 2010.
- Freitas F, Virgolino M, Ribeiro C. Infecção de prótese articular da anca e joelho. Revista Portuguesa de Ortopedia e Traumatologia. 2013: 165–172.
- Garrido-Gómez J, Arrabal-Polo MA, Girón-Prieto MS, et al. Descriptive analysis of the economic costs of periprosthetic joint infection of the knee for the public health system of Andalusia. J Arthroplasty. 2013;28:1057–1060. doi: 10.1016/j.arth.2013.02.012
- Taylor EN, Webster TJ. The use of superparamagnetic nanoparticles for prosthetic biofilm prevention. Int J Nanomed. 2009;4:145–152. doi: 10.2217/17435889.4.2.145
- Moura J, Baylina P, Moreira P. Exploring the real costs of healthcare-associated infections: an international review. Int J Healthcare Manage. 2017: 1–8. doi:10.1080/20479700.2017.1330729.
- Veillard J, Guisset A-L, Garcia-Barbero M. Selection of indicators for hospital performance measurement. A Report on the 3rd and 4th WHO Workshop Barcelona, Spain, June and September: 2003.
- WHO. Measuring hospital performance to improve the quality of care in Europe: a need for clarifying the concepts and defining the main dimension. Report on a WHO Workshop Barcelona, Spain. 2003: 10–11.
- Tumbarello M, Repetto E, Trecarichi E, et al. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. Epidemiol Infect. 2011;139:1740–1749. doi: 10.1017/S0950268810003055
- Plowman R. The socioeconomic burden of hospital acquired infection. Euro Surveill. 2000;5:49–50. doi: 10.2807/esm.05.04.00004-en
- Bôas P, Ruiz T. Ocorrência de infecção hospitalar em idosos internados em hospital universitário. Rev Saúde Pública. 2004;38:372–378. doi: 10.1590/S0034-89102004000300006
- Kirkland KB, Briggs JP, Trivette SL, et al. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725–730. doi: 10.1086/501572
- Rocha LÁ. Vigilancia de la infección nosocomial en la UCI. Medicina Intensiva. 2002;26:61–63. doi: 10.1016/S0210-5691(02)79737-4